• / Free eNewsletters & Magazine
  • / My Account
Home>Soft Tissue Repair Market - Expected to Reach $10.7 Billion by 2025 - Research and Markets

Soft Tissue Repair Market - Expected to Reach $10.7 Billion by 2025 - Research and Markets

Soft Tissue Repair Market - Expected to Reach $10.7 Billion by 2025 - Research and Markets

09/29/2017

Soft Tissue Repair Market - Expected to Reach $10.7 Billion by 2025 - Research and Markets

The "Soft Tissue Repair Market, 2014-2025" report has been added to Research and Markets' offering.

The global soft tissue repair market is expected to reach USD 10.73 billion by 2025. Growing number of trauma patients and orthopedic surgeries is one of the key factors expected to drive revenue growth in coming few years.

Factors influencing soft tissue repair market growth are growing number of patients suffering from sports related injuries. Sprains, contusions, strains, tendinitis, and bursitis are some common injuries, that are suffered by athletes. Growing awareness about impact of these injuries on athletes' performance and awareness regarding available treatment options for soft tissue repair are expected to promote revenue growth of the soft tissue repair market. Ageing population is another significant factor promoting revenue growth. Old people are more susceptible to fractures and trauma associated injury and often require joint replacement and reconstruction surgeries.

According to a United Nations report in 2015, the population of people aged 60 years and above is projected to grow by 56% and is expected to reach 1.4 billion by 2030. This in turn is expected to bolster the patient pool for joint replacement and soft tissue repair surgeries and in turn propel revenue growth of the market over the forecast period.

Companies Mentioned

  • Stryker Corporation
  • Arthrex, Inc.
  • Integra LifeScience Corporation
  • Smith & Nephew, Inc.
  • Depuy Synthes
  • Baxter
  • Admedus
  • St Jude Medical
  • LeMaitre Vascular Inc.
  • Edwards Life Sciences Corporation
  • Cryolife, Inc.
  • Terumo Medical Corporation
  • Bard Peripheral Vascular Inc.
  • W.L. Gore & Associates, Inc.

Key Topics Covered:

Chapter 1. Methodology and Scope

©2017 Morningstar Advisor. All right reserved.